Key Events This Week
Jan 19: Stock hits 52-week low at Rs.110.20 amid market pressure
Jan 20: New 52-week low at Rs.107.25; Mojo Grade downgraded to Sell
Jan 21: Further 52-week low at Rs.105.40 despite intraday gains
Jan 22: Reports sharp quarterly financial decline; stock rebounds +3.03%
Jan 23: Stock closes week at Rs.118.30, up 2.42% on the day

Indo US Bio-Tech Ltd Reports Sharp Decline in Quarterly Financials Amid Negative Trend Shift
2026-01-22 08:00:17Indo US Bio-Tech Ltd has reported a significant downturn in its latest quarterly financial performance, marking a shift from a previously flat to a negative financial trend. The company’s December 2025 quarter results reveal contraction across key metrics including revenue, profitability, and earnings per share, signalling challenges ahead for this player in the Other Agricultural Products sector.
Read full news article
Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Underperformance
2026-01-20 11:46:35Indo US Bio-Tech Ltd’s stock declined sharply to a new 52-week low of Rs.109.7 today, marking a significant drop amid a challenging market environment and subdued financial performance. The stock’s fall contrasts with the broader market’s mixed movements, highlighting company-specific pressures.
Read full news article
Indo US Bio-Tech Downgraded to Sell Amid Technical Weakness and Flat Financials
2026-01-20 08:30:06Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and a challenging near-term outlook despite some strong long-term fundamentals. The company’s Mojo Score has declined to 47.0, signalling caution for investors amid a 3.8% drop in share price on the downgrade day.
Read full news article










